CFY 196

Drug Profile

CFY 196

Alternative Names: CFY-196; ColdSol

Latest Information Update: 17 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Perlan Therapeutics
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action Immunostimulants; Intercellular adhesion molecule 1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Common cold

Most Recent Events

  • 06 May 2003 Preclinical trials in Common cold in USA (unspecified route)
  • 06 May 2003 Data presented at the International Conference of Antiviral Research (ICAR-2003) have been added to the Viral infections pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top